HSD3B1 and resistance to androgen-deprivation therapy in prostate cancer: a retrospective, multicohort study
- 1 October 2016
- journal article
- research article
- Published by Elsevier in The Lancet Oncology
- Vol. 17 (10) , 1435-1444
Abstract
No abstract availableKeywords
Funding Information
- Prostate Cancer Foundation
- National Institutes of Health
- US Department of Defense
- Howard Hughes Medical Institute
- American Cancer Society
- Conquer Cancer Foundation
- American Society of Clinical Oncology
- Cleveland Clinic Research Programs Committee
- Department of Radiation Oncology
- Gail and Joseph Gassner Development Funds
- Department of Radiation Oncology
- US Department of Defense
- Conquer Cancer Foundation
- American Society of Clinical Oncology
- Prostate Specialized Program of Research Excellence (P50-CA091956)
- Gail and Joseph Gassner Development Funds
- Howard Hughes Medical Institute
- Prostate Cancer Foundation
- American Cancer Society
- US Army Medical Research and Materiel Command (W81XWH-09–1-0301)
- National Institutes of Health (R01CA172382, R01CA190289, R01CA168899)
This publication has 41 references indexed in Scilit:
- Increased Survival with Enzalutamide in Prostate Cancer after ChemotherapyNew England Journal of Medicine, 2012
- Comparison of a multiplexed MassARRAY system with real-time allele-specific PCR technology for genotyping of methicillin-resistant Staphylococcus aureusClinical Microbiology and Infection, 2011
- SLCO2B1andSLCO1B3May Determine Time to Progression for Patients Receiving Androgen Deprivation Therapy for Prostate CancerJournal of Clinical Oncology, 2011
- Abiraterone and Increased Survival in Metastatic Prostate CancerNew England Journal of Medicine, 2011
- Expression of SLCO Transport Genes in Castration-Resistant Prostate Cancer and Impact of Genetic Variation in SLCO1B3 and SLCO2B1 on Prostate Cancer OutcomesCancer Epidemiology, Biomarkers & Prevention, 2011
- Genotyping of DNA Samples Isolated from Formalin-Fixed Paraffin-Embedded Tissues Using PreamplificationThe Journal of Molecular Diagnostics, 2010
- Assessing outcomes in prostate cancer clinical trialsCancer, 2008
- Maintenance of Intratumoral Androgens in Metastatic Prostate Cancer: A Mechanism for Castration-Resistant Tumor GrowthCancer Research, 2008
- Immediate Hormonal Therapy Compared with Observation after Radical Prostatectomy and Pelvic Lymphadenectomy in Men with Node-Positive Prostate CancerNew England Journal of Medicine, 1999
- A Controlled Trial of Leuprolide with and without Flutamide in Prostatic CarcinomaNew England Journal of Medicine, 1989